Demographic, health behavioral, and self‐management abilities associated with disease severity among patients with chronic obstructive pulmonary disease: An exploratory study

Wang, Lan; Tao, Yadong; Dong, Xiaoyan; Zhang, Qing; Zheng, Hong; Zheng, Yashu; Xing-yue, Tang; Xu, Jing-Rui; Zhao, Yue

doi:10.1111/ijn.12509

Cited by 8 publications

(8 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The DOSE index comprises Dyspnoea, airflow Obstruction, Smoking status and COPD Exacerbation components (Table 1), 10 and has been shown to be associated with respiratory failure and healthcare utilisation, 10 future exacerbation, 11 mortality, 12,13 physical activity and BMI, 14 and worsening health status as measured by self-reported Clinical COPD Questionnaire. 15 Several practical advantages further commend its use in primary care in preference to other available indices.…”

Section: Introductionmentioning

confidence: 99%

Primary care risk stratification in COPD using routinely collected data: a secondary data analysis

Johnson

Rigge

Culliford

et al. 2019

npj Prim. Care Respir. Med.

View full text Add to dashboard Cite

Most clinical contacts with chronic obstructive pulmonary disease (COPD) patients take place in primary care, presenting opportunity for proactive clinical management. Electronic health records could be used to risk stratify diagnosed patients in this setting, but may be limited by poor data quality or completeness. We developed a risk stratification database algorithm using the DOSE index (Dyspnoea, Obstruction, Smoking and Exacerbation) with routinely collected primary care data, aiming to calculate up to three repeated risk scores per patient over five years, each separated by at least one year. Among 10,393 patients with diagnosed COPD, sufficient primary care data were present to calculate at least one risk score for 77.4%, and the maximum of three risk scores for 50.6%. Linked secondary care data revealed primary care under-recording of hospital exacerbations, which translated to a slight, non-significant cohort average risk score reduction, and an understated risk group allocation for less than 1% of patients. Algorithmic calculation of the DOSE index is possible using primary care data, and appears robust to the absence of linked secondary care data, if unavailable. The DOSE index appears a simple and practical means of incorporating risk stratification into the routine primary care of COPD patients, but further research is needed to evaluate its clinical utility in this setting. Although secondary analysis of routinely collected primary care data could benefit clinicians, patients and the health system, standardised data collection and improved data quality and completeness are also needed.

show abstract

Section: Introductionmentioning

confidence: 99%

Primary care risk stratification in COPD using routinely collected data: a secondary data analysis

Johnson

Rigge

Culliford

et al. 2019

npj Prim. Care Respir. Med.

View full text Add to dashboard Cite

show abstract

“…Thus, it became clear that SM skills should not be evaluated as a single component but should be evaluated together with various components that may have an effect, especially SpM. In various studies, it has been reported that the COPD stage is effective in SpM as in our study (Chen et al, 2016;Wang et al, 2017), whereas some studies have revealed a negative correlation (Chen et al, 2008;Vogelmeier et al, 2020). These results in the literature are associated with the fact that the parameters that may be effective in COPD self-management have only been researched to a limited extent.…”

Section: F I G U R Ementioning

confidence: 64%

Impact of COPD stage on self management with COPD patients: The mediating role of symptoms management

Ceyhan,

Aydin

2024

Journal of Clinical Nursing

View full text Add to dashboard Cite

AimsIt is extremely important to determine the relationship between COPD and self‐management (SM) in the disease process. However, the impact of symptom management (SpM) on this relationship is still unclear. The study aimed to examine the mediating role of SpM in the effect of the COPD stage on SM.DesignA predictive correlational study was reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.MethodsThis study was conducted between 15 February 2023 and 15 June 15 2023, with 306 patients. Data were collected using the Symptom Management Scale for Self‐Efficacy and the Chronic Disease Self‐Management Scale. Descriptive statistics and Process Macro Model 4 in the SPSS program were used for data analysis.ResultsMost of the patients were in the moderate stage of COPD; their SM scores were at low levels; SpM scores were at moderate levels. The model was significant, and the variables explained 65% of the model. The COPD stage was significantly positively correlated with SpM and negatively correlated with SM. There was a significant positive impact between SpM and SM. The positive and significant standardised indirect effect of SpM on SM evidenced a full mediating effect.ConclusionsSymptom management has a full mediating role in the effect of the COPD stage on SM. It was revealed that the level of SM can be increased by achieving SpM.Implications for the Profession and/or Patient CareSymptoms are vital in COPD. Progression of COPD increases symptom severity. Being successful in SpM greatly contributes to the achievement of self‐management. Therefore, nurses should definitely consider symptom control in strengthening self‐management in the care of patients with COPD.Patient or Public ContributionPatients' COPD stage was determined by a pulmonologist involved in the study. Voluntary patients with COPD hospitalised in the pulmonology clinic were included in the study.

show abstract

“…In our study, the mean dose at a stable state at 6 months was 2.88 ± 1.745. 28 Zhang et al concluded in their study that the DOSE index stays significant when comparing the change between the outcomes between the periods of the study. They demonstrated the relative predictability of the DOSE index as a measure of health outcomes among a group of Chinese patients.…”

Section: Dose Indexmentioning

confidence: 98%

Dyspnea, Obstruction, Smoking, Exacerbation Index, and Chronic Obstructive Pulmonary Disease Test Score: Correlation in Predicting Outcomes in Patients with Chronic Obstructive Pulmonary Disease Exacerbations

Kumar¹,

Mishra²,

Daga³

et al. 2022

The Indian Journal of Chest Diseases and Allied Sciences

View full text Add to dashboard Cite

Objectives: Chronic obstructive pulmonary disease (COPD) being a disease with systemic consequences necessitate the use of multidimensional indices for a comprehensive assessment of the disease's impact including the future risk of exacerbations and mortality. To study the role of dyspnea, obstruction, smoking, and exacerbation (DOSE) index as a predictor of future disease severity and its correlation with chronic obstructive pulmonary disease test (CAT) score. Measurements and results: A total of 60 inpatients with COPD exacerbations were followed up for 6 months to record the number of exacerbations of COPD. The DOSE index and CAT score were calculated after stabilization within 48 hours of admission, at 1 week, and again at 6 months. The mean difference between DOSE index score at admission and at 1 week was 1.382 ± 0.561 and at admission and at 6 months was 2.15 ± 0.988, both being statistically significant (p < 0.001). A high DOSE index score (≥4) was associated with a greater risk of 2 or more exacerbations [odds ratio (OR), 12 (3.09-46.60) and risk estimate, 3.75 (1.53-9.17)]. For the prediction of exacerbations, the area under the curve (AUC) was larger for the DOSE index (0.854) than the global initiative for chronic obstructive lung disease (GOLD) stage (0.789), p < 0.001 for both. Furthermore, DOSE index correlated significantly with the CAT score, an established health status measure, at all stages of disease severity; at the onset of exacerbation (r = 0.719, p < 0.001), after stabilization at 1 week (r = 0.736, p < 0.001) and at 6 months (r = 0.884, p < 0.001). Conclusion:The DOSE index is a simple, practical multidimensional grading tool for assessing current symptoms, health status, and future risk in COPD and acts as a guide to disease management as its component items can be modified by interventions. Its correlation with CAT, a wellknown score is a novel observation, which further corroborates the validity of the DOSE index.

show abstract

Demographic, health behavioral, and self‐management abilities associated with disease severity among patients with chronic obstructive pulmonary disease: An exploratory study

Cited by 8 publications

References 30 publications

Primary care risk stratification in COPD using routinely collected data: a secondary data analysis

Primary care risk stratification in COPD using routinely collected data: a secondary data analysis

Impact of COPD stage on self management with COPD patients: The mediating role of symptoms management

Dyspnea, Obstruction, Smoking, Exacerbation Index, and Chronic Obstructive Pulmonary Disease Test Score: Correlation in Predicting Outcomes in Patients with Chronic Obstructive Pulmonary Disease Exacerbations

Contact Info

Product

Resources

About